关于新型EGFR/HER2抑制剂的抗癌潜力和结构-活性关系 (SAR) 的审查
Subhadip Maity1, Priya Devi1, Aastha Singh1
1Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab, India.
Current topics in medicinal chemistry
|June 27, 2025
概括
开发针对人类表皮生长受体2 (HER2) 和表皮生长因子受体 (EGFR) 的新型双抑制剂对于精确的癌症治疗至关重要. 这项研究确定了新的分子,以克服乳腺和肺癌当前治疗方法的局限性.
科学领域:
- 在瘤学瘤学.
- 药用化学 医学化学
- 分子生物学分子生物学
背景情况:
- 人体表皮生长受体 (HER),包括EGFR/HER1,HER2,HER3和HER4,是细胞信号通路的关键调节者.
- HER受体的过度表达与各种癌症的发展和进展有关.
- 目前的EGFR/HER2双抑制剂面临选择性,特异性,副作用和耐药性的挑战.
研究的目的:
- 识别和开发针对EGFR和HER2进行癌症治疗的新型治疗分子.
- 探索潜在EGFR/HER2双抑制剂的不同结构类别.
- 为设计下一代EGFR/HER2双抑制剂提供洞察力,以改善治疗潜力.
主要方法:
- 对EGFR/HER2双抑制剂的现有文献进行审查和分析.
- 专注于不同化学架构的结构-活动关系 (SAR).
- 包括来自临床试验和专利申请的数据.
- 分子对接研究,以评估强效化合物的结合亲和力.
主要成果:
- 突出 EGFR/HER2 双重抑制剂的各种结构类别,包括 胺, 纳, 胺, 胺, 胺和 胺衍生物.
- 讨论SAR,临床数据和专利环境对于化合物开发的重要性.
- 确定开发精确且毒性较低的EGFR/HER2双抑制剂的关键挑战.
结论:
- 新型EGFR/HER2双抑制剂的开发对于克服现有治疗方法的局限性至关重要.
- 药物和有机化学家正在积极设计新的分子,以提高精度和降低毒性.
- 对结构-活性关系和分子相互作用的进一步研究将指导发现乳腺和肺癌中强大的EGFR/HER2双抑制剂.
更多相关视频
相关概念视频
02:38Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:28Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.3K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.3K